TELZYMBIO

Serial Number 79382513
Registration 7445426
700

Registration Progress

Application Filed
Sep 20, 2023
Under Examination
Approved for Publication
Apr 30, 2024
Published for Opposition
Apr 30, 2024
Registered
Jul 16, 2024

Trademark Image

TELZYMBIO

Basic Information

Serial Number
79382513
Registration Number
7445426
Filing Date
September 20, 2023
Registration Date
July 16, 2024
Published for Opposition
April 30, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 16, 2024
Registration
Registered
Classes
005

Rights Holder

IO Biotech ApS

99
Address
Ole Maaløes Vej 3
DK-2200 Copenhagen N
DK

Ownership History

IO Biotech ApS

Original Applicant
99
DK

IO Biotech ApS

Owner at Publication
99
DK

IO Biotech ApS

Original Registrant
99
DK

Legal Representation

Attorney
Bryce J. Maynard

USPTO Deadlines

Next Deadline
1826 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-16)
Due Date
July 16, 2030
Grace Period Ends
January 16, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Apr 19, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Mar 31, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 31, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jan 17, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Dec 29, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Dec 29, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Oct 18, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jul 16, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 16, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 16, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 30, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 26, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 5, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 5, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 5, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 5, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 25, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 24, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 23, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Dec 30, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Dec 30, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 20, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 19, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 18, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 6, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 2, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines

Classification

International Classes
005